Syncona shares jump 9% on sale of Gyroscope Therapeutics
Shares in healthcare investor Syncona (SYNC) jumped 9% to 217.5p on Wednesday, topping the FTSE 250 leaderboard, after the company announced the sale of gene therapy specialist Gyroscope Therapeutics for up to $1.5 billion to Swiss...
22 December 2021